Ding Z - Search Results

1

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y, Shen H, Tong R, Wang W, Li L, Song J, Li J, Su X, Ding Z, Gong Y, Zhu J, Wang Y, Zou B, Zhang Y, Li Y, Zhou L, Liu Y, Yu M, Wang Y, Zhang X, Yin L, Xia X, Zeng Y, Zhou Q, Ying B, Chen C, Wei Y, Li W, Mok T. Lu Y, et al. Among authors: ding z. Nat Med. 2020 May;26(5):732-740. doi: 10.1038/s41591-020-0840-5. Epub 2020 Apr 27. Nat Med. 2020. PMID: 32341578 Clinical Trial.

2

Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.

Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X, Zhang L, Zhou Q, Wei YQ. Li G, et al. Clin Cancer Res. 2005 Jun 1;11(11):4217-24. doi: 10.1158/1078-0432.CCR-04-2117. Clin Cancer Res. 2005. PMID: 15930360

3

Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2.

Luo Y, Wen YJ, Ding ZY, Fu CH, Wu Y, Liu JY, Li Q, He QM, Zhao X, Jiang Y, Li J, Deng HX, Kang B, Mao YQ, Wei YQ. Luo Y, et al. Clin Cancer Res. 2006 Mar 15;12(6):1813-9. doi: 10.1158/1078-0432.CCR-05-1990. Clin Cancer Res. 2006. PMID: 16551866

4

[Anti-tumor effects of recombinant adenovirus encoding survivin encapsulated in cationic liposome].

Yang YL, Ding ZY, Li Q, Zhou H, Deng HX, Tian L, Wei YQ. Yang YL, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Sep;37(5):704-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17037732 Chinese.

5

[Investigation of role in antitumor immune of mouse recombinant alpha-fetoprotein conjugated with mannan].

Zhang W, Wei YQ, Chen LJ, Liu JY, Wu Y, Ding ZY, Wen YJ, Yang JL, Fan LY, Li J, Kan B, Deng HX. Zhang W, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Nov;37(6):830-4. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17236574 Chinese.

6

Therapeutic vaccine for melanoma: the untouched grail?

Ding Z, Wei Y. Ding Z, et al. Expert Rev Vaccines. 2007 Dec;6(6):907-11. doi: 10.1586/14760584.6.6.907. Expert Rev Vaccines. 2007. PMID: 18377354

7

A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus.

Zhao JM, Wen YJ, Li Q, Wang YS, Wu HB, Xu JR, Chen XC, Wu Y, Fan LY, Yang HS, Liu T, Ding ZY, Du XB, Diao P, Li J, Wu HB, Kan B, Lei S, Deng HX, Mao YQ, Zhao X, Wei YQ. Zhao JM, et al. FASEB J. 2008 Dec;22(12):4272-80. doi: 10.1096/fj.08-110049. Epub 2008 Aug 20. FASEB J. 2008. PMID: 18716030

8

Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis.

Du XB, Lang JY, Xu JR, Lu Y, Wen YJ, Zhao JM, Diao P, Yuan ZP, Yao B, Fan LY, Wang GQ, Liu L, Ding ZY, Wang YS, Li T, Wang R, Mao YQ, Kan B, Wu HB, Li HX, Yang HS, Wu HB, Wei YQ, Zhao X. Du XB, et al. Apoptosis. 2008 Oct;13(10):1205-14. doi: 10.1007/s10495-008-0253-2. Epub 2008 Aug 25. Apoptosis. 2008. PMID: 18726188

9

PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.

Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X. Yuan Z, et al. Among authors: ding zy. Cancer Chemother Pharmacol. 2009 Dec;65(1):13-25. doi: 10.1007/s00280-009-0998-5. Epub 2009 Apr 22. Cancer Chemother Pharmacol. 2009. PMID: 19387645

10

Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis.

Yang H, Wang C, Wang R, Deng H, Ding Z, Yang J, Lu Y, Li J, Zhang P, Mao Y, Kan B, Wei L, Peng F, Wei Y. Yang H, et al. Among authors: ding z. J Biosci Bioeng. 2009 Jun;107(6):589-95. doi: 10.1016/j.jbiosc.2009.02.005. J Biosci Bioeng. 2009. PMID: 19447332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,787 results

Search Page